Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0938-0964
ICR Reference No:
201312-0938-021
Status:
Historical Active
Previous ICR Reference No:
201203-0938-004
Agency/Subagency:
HHS/CMS
Agency Tracking No:
21180
Title:
Medicare Prescription Drug Benefit Program
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
02/06/2014
Retrieve Notice of Action (NOA)
Date Received in OIRA:
12/27/2013
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
02/28/2017
36 Months From Approved
02/28/2014
Responses
46,099,845
0
41,278,271
Time Burden (Hours)
7,572,223
0
35,582,601
Cost Burden (Dollars)
0
0
0
Abstract:
The voluntary prescription drug benefit program was enacted into law on December 8, 2003 in section 101 of Title I of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The MMA specifies that the prescription drug benefit program will be available to beneficiaries on January 1, 2006. Coverage for the prescription drug benefit will be provided under private prescription drug plans, or through Medicare Advantage prescription drug plans. Organizations offering drug plans will have flexibility in the design of the prescription drug benefit.
Authorizing Statute(s):
Statute at Large:
18 Stat. 1860
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
78 FR 61848
10/04/2013
30-day Notice:
Federal Register Citation:
Citation Date:
78 FR 75926
12/03/2013
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
3
IC Title
Form No.
Form Name
Medicare Prescription Drug Benefit Program (PLAN)-(CMS-10141)
CMS-10141, CMS-10141
Writing Agents Information Sheet
,
Compensation Structure for Writing Agents by Contract/PBP Number
Medicare Prescription Drug Benefit Program (Benes)
State Eligibility Determinations [423.904(b)] and Reporting [423.910(d)]
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
46,099,845
41,278,271
0
0
4,821,574
0
Annual Time Burden (Hours)
7,572,223
35,582,601
0
0
-28,010,378
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
While there are no program changes, this is a revised collection. Overall, the annual hour burden has decreased 28,010,378 hr (from 35,582,601 to 7,572,223 hr). The differences in the burden estimate are due to factors such as decreases in the number of Part D contracts and in the number of new Part D enrollees. Our additional experience with the program as well as data reported by the Part D sponsors have also enabled us to refine our previous estimates, resulting in a number of significant changes to the burden. More specifically, in ?? 423.120, 423.128, 423.153, and 423.505, the decreased burden is due to decreases in the number of Part D sponsors. Other changes were based on additional program experience that permitted a refinement of our previous estimates of burden hours or number of responses. In ?? 423.32, 423.44, 423.56, 423.564, 423.568, 423.570, 423.572, and 423.578, the decreased burden occurred because of decreases in the number of people newly enrolling in Part D and in the number of Part D sponsors. Other changes to burden requirements were due to the correction of errors in previous calculations, new regulatory requirements associated with Part D IRMAA and additional experience with the program that permitted a refinement of the estimates. Finally, in ?? 423.329, 423.336, 423.343, and 423.892 the increase in burden occurred because of adjustments made to the number of sponsors included in the estimates.
Annual Cost to Federal Government:
$698
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
12/27/2013
An official website of the United States government
The .gov means it's official.
The site is secure.
